DM
JBIO

Deerfield Management’s Jade Biosciences JBIO Stock Holding History

Deerfield Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-531,163
Closed -$4.58M – 152
2025
Q3 		$4.58M Hold
531,163
– – 0.07% 73
2025
Q2 		$5.31M Buy
+531,163
New +$18.1M 0.1% 74
2024
Q4 		– Sell
-40,332
Closed -$2.95M – 144
2024
Q3 		$2.95M Hold
40,332
– – 0.04% 76
2024
Q2 		$2.34M Buy
+40,332
New +$26.7M 0.04% 77
2021
Q4 		– Sell
-20,408
Closed -$15M – 130
2021
Q3 		$15M Hold
20,408
– – 0.29% 81
2021
Q2 		$16.3M Buy
+20,408
New +$16.3M 0.29% 91

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return